
Profile
General Information
Neurex Corporation received marketing clearance from the U.S. Food and Drug Administration (FDA) for Corlopam. Corlopam is an intervenous treatment for severe high blood pressure. Corlopam is administered in the hospital over a six-hour to 48-hour period to relieve severe hypertensive spikes.
Approval Date: 1997-09-01
Company Name: Neurex